1. Home
  2. MCY vs BLCO Comparison

MCY vs BLCO Comparison

Compare MCY & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mercury General Corporation

MCY

Mercury General Corporation

HOLD

Current Price

$109.58

Market Cap

5.8B

Sector

Finance

ML Signal

HOLD

Logo Bausch + Lomb Corporation

BLCO

Bausch + Lomb Corporation

HOLD

Current Price

$17.21

Market Cap

5.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MCY
BLCO
Founded
1961
1853
Country
United States
Canada
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Ophthalmic Goods
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.8B
5.4B
IPO Year
1995
2022

Fundamental Metrics

Financial Performance
Metric
MCY
BLCO
Price
$109.58
$17.21
Analyst Decision
Strong Buy
Buy
Analyst Count
1
11
Target Price
$100.00
$18.45
AVG Volume (30 Days)
252.3K
363.0K
Earning Date
05-05-2026
04-29-2026
Dividend Yield
1.33%
N/A
EPS Growth
15.62
N/A
EPS
3.44
N/A
Revenue
$5,992,468,000.00
$5,101,000,000.00
Revenue This Year
$5.16
$8.65
Revenue Next Year
$5.59
$5.59
P/E Ratio
$32.12
N/A
Revenue Growth
9.44
6.47
52 Week Low
$65.77
$13.09
52 Week High
$111.46
$18.92

Technical Indicators

Market Signals
Indicator
MCY
BLCO
Relative Strength Index (RSI) 68.78 73.08
Support Level $84.77 $16.26
Resistance Level N/A $17.52
Average True Range (ATR) 2.78 0.45
MACD 0.58 0.24
Stochastic Oscillator 92.45 96.54

Price Performance

Historical Comparison
MCY
BLCO

About MCY Mercury General Corporation

Mercury General Corp is an insurance holding company. It is engaged in writing personal automobile insurance and provides related property and casualty insurance products. The company offers the following types of automobile coverage: collision, property damage, bodily injury (BI), comprehensive, personal injury protection (PIP), underinsured and uninsured motorist, and other hazards. Additionally, it offers the following types of homeowners coverage: dwelling, liability, personal property, and other coverages. The company has one reportable business segment, the Property and Casualty business segment.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Share on Social Networks: